Safety and tolerability of oral vorolanib for neovascular (wet) age-related macular degeneration: a phase i, open-label study

HIGHLIGHTS

• who: Yunxia Gao from the (UNIVERSITY) have published the Article: Safety and tolerability of oral vorolanib for neovascular (wet) age-related macular degeneration: a phase I, open-label study, in the Journal: (JOURNAL) of 18/08/2022
• what: The authors aimed to explore the safety and pharmacokinetics (PK) as well as preliminary efficacy of oral vorolanib in participants with nAMD. This study was approved by the local institutional review board at each participating site and conducted in accordance with the Declaration of Helsinki. This study has several limitations, such as a small sample size, no . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.